"The Effect of Aerobic Exercise and Strength Training on Physical Activity Level, Quality of Life and Anxiety-Stress Disorder in Young Adults With and Without Covid-19"

Sponsor
Pamukkale University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT06145386
Collaborator
(none)
30
1
2
23.3
1.3

Study Details

Study Description

Brief Summary

The purpose of this study; to examine the effects of aerobic and strength training on physical activity level, quality of life and anxiety-stress disorder in young adults with and without COVID-19. In this context, the study was planned by including 15 participants between the ages of 18-25 who had COVID-19 and 15 who did not have COVID-19. Data were collected by applying the Personal Data Form, IPAQ (International Physical Activity Form), SF-36 Quality of Life Scale, Coronavirus Anxiety Scale (CCS), Respiratory Function Tests (PFT), Six Minute Walk Test (6MWT). Aerobic training and strengthening training were applied to people with and without COVID-19 for 12 weeks. Aerobic exercise (walking) was given for 40 minutes 5 days a week, with the target heart rate being 70% of the age-corrected maximum heart rate. Strengthening exercises were applied to the upper (triceps, biceps, deltoid, pectorals) and lower (quadriceps, hamstring, gastrocnemius, tibialis anterior, hip adductors, hip flexors, hip extensors) extremities and back muscles (trapezius, latissimus dorsi) with theraband (resistance band). Significance test of the difference between two means in comparing independent group differences when parametric test assumptions are met for statistical analysis in line with the data collected from the participants; When parametric test assumptions are not met, Mann Whitney U test is used to compare independent group differences, while when parametric test assumptions are met to examine dependent group differences, the significance test of the difference between the two spouses is used; When parametric test assumptions were not met, the Wilcoxon paired two sample test was used. In all analyses, p < .05 was considered statistically significant.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Aerobic Exercise and Strength Training
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
"The Effect of Aerobic Exercise and Strength Training on Physical Activity Level, Quality of Life and Anxiety-Stress Disorder in Young Adults With and Without Covid-19"
Actual Study Start Date :
Feb 21, 2022
Anticipated Primary Completion Date :
Jan 21, 2024
Anticipated Study Completion Date :
Jan 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: COVID-19 positive

Behavioral: Aerobic Exercise and Strength Training
Aerobic Exercise and Strength Training on Physical Activity Level, Quality of Life and Anxiety-Stress Disorder in Young Adults With and Without Covid-19

Experimental: COVID-19 negative

Behavioral: Aerobic Exercise and Strength Training
Aerobic Exercise and Strength Training on Physical Activity Level, Quality of Life and Anxiety-Stress Disorder in Young Adults With and Without Covid-19

Outcome Measures

Primary Outcome Measures

  1. International Physical Activity Questionnaire [5 minute]

    Used to define participants physical activity level

  2. SF-36 [10 minute]

    Used to indicate the health status of participants

  3. Coronavirus Anxiety Scale [1 minute]

    Used to evaluate experience some psychological problems such as anxiety and depression depends on COVID-19

  4. Respiratory Function Tests [5 minute]

    Used to evaluation of the respiratory system

  5. The 6 Minute Walk Test [6 minute]

    Used to assess aerobic capacity and endurance

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 25 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Volunteering to participate in the study,

  • Able to communicate, without hearing and/or visual impairment,

  • Being between the ages of 18-25

  • Not having a systemic disease

  • Having had COVID-19 in the last 6 months to be included in the study group

Exclusion Criteria:
  • Unable to communicate, hearing and/or visually impaired,

  • Not being between the ages of 18-25

  • Having a systemic disease other than COVID-19 infection,

  • Having had COVID-19 more than 6 months ago.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Istanbul Aydin University Istanbul Kücükcekmece Turkey

Sponsors and Collaborators

  • Pamukkale University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ozge Mine Yilmaz, PhD Student, Pamukkale University
ClinicalTrials.gov Identifier:
NCT06145386
Other Study ID Numbers:
  • Pamukkale Universityy
First Posted:
Nov 24, 2023
Last Update Posted:
Nov 29, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ozge Mine Yilmaz, PhD Student, Pamukkale University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 29, 2023